Physician profile
Candace Westgate
NPI 1669607735
$123,250.77
in general payments reported to CMS, 2019-2025
32 companies · $2,333 in 2025
The $2,333 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $280 · 2021: $9,244 · 2022: $29K · 2023: $65K · 2024: $18K · 2025: $2,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $60K · Travel and Lodging: $10K · Consulting Fee: $9,300 · Food and Beverage: $3,164 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,700 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $59,850.00 |
| Travel and Lodging | $10,425.30 |
| Consulting Fee | $9,300.00 |
| Food and Beverage | $3,163.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,700.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $60,551.71 | 2021-2024 | Myrisk, Mychoice Cdx |
| Myriad Women'S Health, INC. | $56,461.17 | 2023 | Myrisk, Genesight |
| Bayer Healthcare Pharmaceuticals INC. | $1,982.33 | 2019-2025 | |
| Applied Medical Resources Corporation | $1,098.01 | 2022 | |
| Astellas Pharma US INC | $485.44 | 2023-2025 | Veozah, Myrbetriq |
| Tempus Ai, INC | $350.21 | 2025 | Xt Cdx, Egg-Af |
| Astrazeneca Pharmaceuticals LP | $345.73 | 2019-2024 | Lynparza |
| Amag Pharmaceuticals, INC. | $239.52 | 2019-2020 | |
| Therapeuticsmd, INC. | $239.40 | 2019-2021 | |
| Organon LLC | $209.09 | 2021-2025 | Nexplanon |
| Abbvie INC. | $188.75 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Ge Healthcare | $180.87 | 2022 | |
| Exact Sciences Corporation | $148.98 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $85.68 | 2023-2025 | |
| Glaxosmithkline, LLC. | $79.23 | 2023 | Brexafemme |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $68.04 | 2021-2022 | |
| Aspira Women'S Health INC | $59.11 | 2022-2024 | Ova1 |
| Hologic Sales and Service, LLC | $56.09 | 2022-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.65 | 2023-2024 | Jardiance |
| Pfizer INC. | $45.99 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $44.55 | 2020-2021 | |
| Baxter Healthcare | $42.87 | 2022 | |
| Biogen, INC. | $42.22 | 2025 | Zurzuvae |
| Millicent US INC | $40.27 | 2025 | Femlyv |
| Shield Therapeutics INC | $28.08 | 2024 | |
| Ethicon US, LLC | $24.86 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $24.16 | 2025 | Opsumit, Uptravi |
| Medtronic, INC. | $17.98 | 2024 | Ligasure |
| Lilly USA, LLC | $17.65 | 2024 | Jardiance, Zepbound |
| Exeltis, USA INC. | $14.59 | 2025 | Slynd |
| Biohaven Pharmaceutical Holding Company LTD. | $13.44 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Westgate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.